Uncommon Therapeutics
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure. Uncommon Therapeutics is a Y Combinator company (Winter 2025). YC-listed status: Active.
- Website
- uncommontherapeutics.com
- Location
- San Francisco, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Uncommon Therapeutics — Developing polytherapy drug treatments for rare genetic diseases, starting with Rett Syndrome. · Other
Links
- Y Combinator profileycombinator